G01N2333/96411

METHOD FOR DETECTING BIOMARKERS

The present invention is directed to methods for using a plurality of particles comprising surfaces each independently comprising a capture moiety to isolate and characterize biomarkers (e.g., for obstructive sleep apnea).

Recombinant factor C and method for producing the same, and method for measuring endotoxin

To provide a method for producing a horseshoe crab recombinant Factor C. The horseshoe crab recombinant Factor C is produced through expression thereof by use of mammalian cells such as CHO DG44 and HEK293 as host cells.

COMPOSITIONS AND METHODS FOR DETECTING AND TREATING PROSTATE CANCER USING PROGASTRIN BINDING MOLECULE
20210087265 · 2021-03-25 · ·

The present invention relates to compositions and methods for the prevention or the treatment of prostate cancer, wherein said compositions comprise an antibody binding to progastrin and said methods comprise the use of an antibody binding to progastrin.

FIBRINOGEN TEST
20210071229 · 2021-03-11 ·

The present invention is related to a novel and direct method for measuring the fibrinogen level in a sample, which is particularly useful in emergency situations. The novel method is independent of thrombin formation and is not interfered by the presence of oral anti-coagulation drugs or other chemicals contrary to the commonly used clotting assays.

USE OF KLK5 ANTAGONISTS FOR THE TREATMENT OF A DISEASE

Provided herein are methods of treating a subject, methods of predicting the response of a subject and selecting a subject suffering from a disease associated with KLK5, such as asthma or Netherton Syndrome. In particular, provided herein are uses of KLK5 antagonists for the treatment or diagnosis of asthma or Netherton Sydrome, such as an antibody or an Fc fusion polypeptide as well as pharmaceutical formulations comprising the same.

METHODS FOR QUANTIFYING DRUG CONCENTRATION IN A PRODRUG COMPOSITION
20200386768 · 2020-12-10 ·

Methods for quantifying the amount of drug present in a prodrug composition are provided.

MOLECULAR SENSOR PREPARATIONS AND USES THEREOF
20200371096 · 2020-11-26 · ·

The present invention relates to a method of preparing a molecular sensor that is specific for a target molecule having a saccharide or peptide region. The method comprises using the target molecule as a template and incubating the template with a receptor to form a template-receptor complex. A molecular scaffold is formed on a surface around the template-receptor complex such that the receptor and at least a portion of the template are embedded in the scaffold, and the template is removed to produce a cavity defined by the scaffold, such that the cavity is complementary to at least a portion of the saccharide or peptide region of the target molecule.

Molecular sensor preparations and uses thereof
10775372 · 2020-09-15 · ·

The present invention relates to a method of preparing a molecular sensor that is specific for a target molecule having a saccharide or peptide region. The method comprises using the target molecule as a template and incubating the template with a receptor to form a template-receptor complex. A molecular scaffold is formed on a surface around the template-receptor complex such that the receptor and at least a portion of the template are embedded in the scaffold, and the template is removed to produce a cavity defined by the scaffold, such that the cavity is complementary to at least a portion of the saccharide or peptide region of the target molecule.

CLINICAL AND IMMUNOLOGIC BIOMARKERS FOR REGRESSION OF HIGH GRADE CERVICAL DYSPLASIA AND CLEARANCE OF HPV16 AND HPV18 INFECTION AFTER IMMUNOTHERAPY
20200282042 · 2020-09-10 ·

Methods for treating a subject infected with human papillomavirus and accompanying symptoms comprise assessing a sample obtained from the patient after the treatment is administered to detect the presence or absence of biomarkers associated with lesion regression and/or clearance of the virus from the subject.

COMPOSITIONS AND METHODS FOR DETECTING PROSTATE CANCER
20200200751 · 2020-06-25 · ·

The present invention relates to compositions and methods for the in vitro diagnosis of prostate cancer, wherein said compositions comprise an antibody binding to progastrin and said methods comprise the use of an antibody binding to progastrin.